Pfizer / 辉瑞

Pfizer / 辉瑞 appears in 130. 谁才是生物医药行业发展的核心驱动力？兼谈创新药产业链的角色分工 as a multinational pharma example. The source uses Pfizer with 罗氏 to show that large pharma companies are not only drug sellers; they also manage investments, acquisition, incubation, portfolio risk, and global commercialization.

156.生物医药的2026：当市场不再为BD躁动，中国药企的星辰大海才刚刚展开 adds Pfizer as the MNC partner in a large 三生制药 BD example. The source uses the deal as evidence that Chinese assets became credible enough for major multinational BD, while still requiring later data validation.

Connections

• Global Pharma Commercialization - broad MNC role.
• Biotech Capital Cycle - corporate cash-flow and BD layer.
• First-In-Class Drug Discovery Role Split - big-company launch and ownership side of the role split.
• SanSheng Pharma / 三生制药 and Platform-Level Biotech BD - episode 156 China BD context.